Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Immunology|July 4, 2014
Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretionJessica Herrath, Karine Chemin, Inka Albrecht, et al.
BMC Immunology|August 7, 2013
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patientsJennifer Pieper, Jessica Herrath, Sukanya Raghavan, et al.
Dermatology and Therapy|April 13, 2026
Patients with Atopic Dermatitis and Insufficient Response to Conventional Systemic Therapy in Germany: A Health Claims Data AnalysisCarolina Schwedhelm, Leonie Kunk, Dorota Pawlowska-Phelan, et al.
European Journal of Immunology|May 25, 2011
The inflammatory milieu in the rheumatic joint reduces regulatory T-cell functionJessica Herrath, Malin Müller, Petra Amoudruz, et al.
European Journal of Immunology|February 2, 2018
EOMES-positive CD4+ T cells are increased in PTPN22 (1858T) risk allele carriersKarine Chemin, Daniel Ramsköld, Lina-Marcela Diaz-Gallo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2015
A Novel HLA-DRB1*10:01-Restricted T Cell Epitope From Citrullinated Type II Collagen Relevant to Rheumatoid ArthritisKarine Chemin, Sabrina Pollastro, Eddie James, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 13, 2019
Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory MyopathiesAngeles S Galindo-Feria, Inka Albrecht, Cátia Fernandes-Cerqueira, et al.
The Journal of Clinical Investigation|November 10, 2015
Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathiesInka Albrecht, Cecilia Wick, Åsa Hallgren, et al.
Pageof 1